Company Quick10K Filing
Opiant Pharmaceuticals
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-12
10-K 2019-12-31 Filed 2020-03-04
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-21
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-29 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-08
10-Q 2017-10-31 Filed 2017-12-04
10-K 2017-07-31 Filed 2017-10-13
10-Q 2017-04-30 Filed 2017-06-14
10-Q 2017-01-31 Filed 2017-03-15
10-Q 2016-10-31 Filed 2016-12-15
10-K 2016-07-31 Filed 2016-10-28
10-Q 2016-04-30 Filed 2016-06-08
10-Q 2016-01-31 Filed 2016-03-15
10-Q 2015-10-31 Filed 2015-12-14
10-K 2015-07-31 Filed 2015-10-26
10-Q 2015-04-30 Filed 2015-06-12
10-Q 2015-01-31 Filed 2015-03-17
10-Q 2014-10-31 Filed 2014-12-09
10-K 2014-07-31 Filed 2014-10-27
10-Q 2014-04-30 Filed 2014-06-10
10-Q 2014-01-31 Filed 2014-03-17
10-Q 2013-10-31 Filed 2013-12-16
10-K 2013-07-31 Filed 2013-10-29
10-Q 2013-04-30 Filed 2013-06-14
10-Q 2013-01-31 Filed 2013-03-18
10-Q 2012-10-31 Filed 2012-12-20
10-K 2012-07-31 Filed 2012-10-29
10-Q 2012-04-30 Filed 2012-06-14
10-Q 2012-01-31 Filed 2012-03-16
10-Q 2011-10-31 Filed 2011-12-15
10-K 2011-07-31 Filed 2011-10-31
10-Q 2011-04-30 Filed 2011-06-13
10-Q 2011-01-31 Filed 2011-03-17
10-Q 2010-10-31 Filed 2010-12-14
10-K 2010-07-31 Filed 2010-11-15
10-Q 2010-04-30 Filed 2010-06-11
10-Q 2010-01-31 Filed 2010-03-16
8-K 2020-08-06 Earnings, Exhibits
8-K 2020-07-28 Enter Agreement, Exhibits
8-K 2020-06-16
8-K 2020-06-05
8-K 2020-05-12
8-K 2020-03-25
8-K 2020-03-20
8-K 2020-03-04
8-K 2020-02-18
8-K 2020-01-17
8-K 2020-01-09
8-K 2020-01-08
8-K 2019-11-14
8-K 2019-11-12
8-K 2019-08-08
8-K 2019-07-11
8-K 2019-06-12
8-K 2019-05-09
8-K 2019-04-09
8-K 2019-03-21
8-K 2019-02-21
8-K 2019-01-15
8-K 2019-01-04
8-K 2018-12-28
8-K 2018-11-07
8-K 2018-11-01
8-K 2018-10-29
8-K 2018-09-27
8-K 2018-09-25
8-K 2018-09-20
8-K 2018-09-10
8-K 2018-08-09
8-K 2018-06-13
8-K 2018-06-12
8-K 2018-06-11
8-K 2018-05-10
8-K 2018-04-18
8-K 2018-02-27
8-K 2018-02-12
8-K 2018-02-08
8-K 2018-01-16
8-K 2018-01-02

Opiant Pharmaceuticals Financials

OPNT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Tanzanian Royalty Exploration (TRX)
International Tower Hill Mines (THM) 99 -30.0 -5% 63 0 0 0 -3 -3 92
Platinum Group Metals (PLG) 52 0% 42 61 0 0 0 0 52
UR-Energy (URG) 94 -11% -13.2 -12% 88 46 21 -2 -11 -7 96
EMX Royalty (EMX) 88 0% 115 6 0 0 0 0 2
Opiant Pharmaceuticals (OPNT) 86 83% 6.0 25% 41 10 33 27 11 10 63
Vista Gold (VGZ) 78 -9.3 -51% 16 2 0 -1 -8 -8 76
Entree Resources (EGI) 72 0% 7 47 0 0 0 0 66
Almaden Minerals (AAU) 72 0% 74 3 0 0 0 0 69
Caledonia Mining (CMCL) 56 0% 126 47 0 0 0 0 56
China Natural Resources (CHNR) 45 0% 8 30 0 0 0 0 45
Pershing Gold (PGLC) 37 -3.0 -36% 32 4 0 -2 -11 -11 35
Avino Silver & Gold Mines (ASM) 37 0% 109 33 0 0 0 0 34
General Moly (GMO) 28 -2.7 -3% 326 58 0 0 -9 -8 22
Golden Minerals (AUMN) 27 35% -4.0 -58% 11 7 4 1 -7 -6 24
Paramount Gold Nevada (PZG) 20 0% -2.7 -11% 54 7 0 0 -6 -6 16
Solitario Zinc (XPL) 17 -5.7 292,300,000% 0 0 0 -3 -3 17
Comstock Mining (LODE) 13 0% -17.4 -10% 35 27 0 0 -4 -1 20
Westwater Resources (WWR) 7 -0.3 -30% 26 10 0 0 -8 -8 3
Kirkland Lake Gold (KL)

Balance Sheet ($MM)2011-10-312012-01-312012-04-302012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-03-312018-06-292018-09-302018-12-312019-03-312019-06-302019-09-30
Cash0000011000011100121113107611112525242423
Accounts Receivable01004023442416
Inventory
PP&E0000000000000
Assets00000110000211001222131011714152929262941
Accounts Payable1
Long-Term Debt0000
Liabilities0011112223357891066777667864139910
Stockholders' Equity-0-0-0-1-1-1-1-2-2-2-3-4-6-7-8-9-5-4-5-56440682517172032
Income Statement ($MM)2011-10-312012-01-312012-04-302012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-03-312018-06-292018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue000000000010107301140402545721
Cost of Revenue00
Gross Profit721
R&D000000000101001-000112222422
SG&A5511012160412211121113224333443
Tax0000000000000000000000100000-00
Net Income-5-5-1-1-1-1-2-2-5-1-4-1-3-2-2-1140-1-111-3-0-6-9-1-1-2211
Cash Flow ($MM)2011-10-312012-01-312012-04-302012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-03-312018-06-292018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-1-0-0-0-0-0-0-0-0-0-0-1-1-1-1-101-2-012-3-3-12-2-1-1-1-1
Cash Investing000000000000-0-0
Cash Financing00000100000211010010-001115110